BRIEF-Citius Pharmaceuticals discontinues Suprenza to focus on core assets
 

BRIEF-Citius Pharmaceuticals discontinues Suprenza to focus on core assets
* Citius Pharmaceuticals discontinues Suprenza to focus on
core assets

Source text for Eikon:
Further company coverage:


(Bengaluru Newsroom: +1-646-223-8780)http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...WI:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...WI:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/VoIQQ30P2DM